NEW YORK, N.Y., July 28, 2020 – Starton Therapeutics Inc. (“Starton” or the “Company”), a biotechnology company focused on transforming standard of care therapeutics, announced today that Pedro Lichtinger, Chairman and Chief Executive Officer, will present a corporate overview at the Private Healthcare Company Virtual Summer Symposium, hosted by LifeSci Partners, on August 4 and 5, 2020.

Please click the following link to register: https://lifesci.events/SummerSymposium

Presentation Details:

Date:  August 5, 2020

Time:  10:30 am Eastern Time

About Starton Therapeutics

A clinical-stage biotechnology company focused on transforming standard of care therapeutics. Starton uses proven transdermal technology with proprietary drivers to obtain new indications or develop on-label superiority for patients with hematological malignancies. To learn more, visit www.www.startontx.com   

Starton Investor Relations:

investors@www.startontx.com

+1 800 449 5405